Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis
Clinical trial NCT04925557 · TERMINATED
Trial details
- NCT number
- NCT04925557
- Sponsor
- State University of New York at Buffalo
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-13
- Primary completion
- 2023-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.